Zipvert-B6 Tablet is a combination pharmaceutical formulation containing Cinnarizine 20mg, Dimenhydrinate 40mg, and Vitamin B6 (Pyridoxine) 10mg, designed for the management of vestibular disorders and associated symptoms such as vertigo, nausea, and vomiting. Cinnarizine, a selective calcium channel blocker, exerts its therapeutic effect by improving blood flow in the inner ear and reducing vestibular sensitivity, thereby alleviating dizziness and balance disturbances. Dimenhydrinate, an antihistamine with antiemetic properties, acts centrally on the vomiting center and vestibular apparatus to prevent motion sickness and control nausea and vomiting. Vitamin B6 (Pyridoxine) is included to support neurological function and may enhance the overall efficacy of the treatment by contributing to the maintenance of normal nerve function. Zipvert-B6 is indicated for the symptomatic relief of motion sickness, vertigo of vestibular origin, and other related conditions. The combination therapy offers a synergistic approach, targeting multiple pathways involved in vestibular dysfunction. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, and caution is advised in patients with hepatic or renal impairment. Adverse effects may include drowsiness, dry mouth, and gastrointestinal discomfort.